The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia.

导出 LinkOut

翻译打印收藏纠错

第一作者： Fangmin,Zhong

第一单位： Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.;National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

作者： Fangmin,Zhong ^[1] ; Xueru,Zhang ^[2] ; Zihao,Wang ^[2] ; Xiaolin,Li ^[2] ; Bo,Huang ^[2] ; Guangyao,Kong ^[3] ; Xiaozhong,Wang ^[2]

作者单位： Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.;National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. ^[1] Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. ^[2] National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. ^[3]

关键词 chronic myeloid leukemia diagnosis ferroptosis immune microenvironment machine learning treatment

主题词人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);肿瘤微环境(Tumor Microenvironment);抗药性, 肿瘤(Drug Resistance, Neoplasm);计算生物学(Computational Biology)

DOI 10.3389/fimmu.2024.1402669

PMID 39026664

发布时间 2024-07-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交